INTRODUCTION
Yellow nail syndrome (YNS) is an uncommon entity first described by Samman and White in 1964 (1) (2) (3) (4) (5) . Classically, it is described as a triad of yellow nail coloration, lymphedema and respiratory tract involvement.
Two of the three classical symptoms are required to confirm the diagnosis of YNS (6, 3) . Almost always, YNS appears in middle-aged persons (7) and has rarely been reported in children (8) . It is a very rare clinical condition and only about 100 cases have been reported since 1995.
The exact etiology is unknown, yet several hypotheses have been proposed. The most common hypothesis emphasizes on a lymphatic anatomical or functional abnormality and a previously published report considered the capillary involvement as a possible cause (9) , suggesting the pathology to be rather acquired than congenital (3). Coincidence with several autoimmune diseases and malignancies has been reported (2), which emphasizes on the importance of diagnostic workup for an underlying disease before starting symptomatic treatment, an approach emphasized by multiple experts. The treatment, although controversial, includes the treatment of the underlying disease (if diagnosed) or it is only symptomatic. The YNS can regress in 7-30% of the cases, spontaneously (2) . Different approaches have been suggested for treatment, most of which with a satisfactory success rate. This case report reviews the literature and 
CASE SUMMARIES
A 34 year-old woman presented with dyspnea, which had begun progressively in the past two months. She also complained of right leg swelling from childhood, and a tendency of koilonychia was noted when she was 18 as picibanil, (20, 19) tetracycline (21) and talk powder (22) .
Other treatment modalities for treatment of YNS available in the literature in order of frequency include: oral and topical alpha-tocopherol (vitamin E) (3, 11, (23) (24) (25) (26) (27) 
